Applying Evidence-Based Medicine to Shared Decision Making: Value of Restricted MeanSurvival Time Zachary R. McCaw, AM, Ariela R. Orkaby, MD, MPH, Lee-Jen Wei, PhD, Dae Hyun Kim, ScD, MD, Michael W. Rich, MD The American Journal of Medicine Volume 132, Issue 1, Pages 13-15 (January 2019) DOI: 10.1016/j.amjmed.2018.07.026 Copyright © 2019 Terms and Conditions
Figure (A) Overall survival in the implantable cardioverter-defibrillator (ICD) and placebo arms of the SCD-HeFT study. (B) Restricted mean survival times, as areas under the Kaplan-Meier curves, for the SCD-HeFT study. SCD-HeFT = Sudden Cardiac Death in Heart Failure Trial. The American Journal of Medicine 2019 132, 13-15DOI: (10.1016/j.amjmed.2018.07.026) Copyright © 2019 Terms and Conditions